BioNxt Solutions Inc.
BNXT.CNCNQHealthcare● Active
$0.41
$-0.02(-3.57%)
Market Cap$52633395
P/E Ratio—
52W High$1.1
52W Low$0.34
BioNxt Solutions Inc. (BNXT.CN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BNXT.CN · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 28, 2025EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 28, 2025
After Market Close
BNXT.CN reports quarterly as a CNQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2025 | Nov 28, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2025 | Jun 20, 2025 | — | -$0.01 | — | — | — | — |
| — Q2 FY2025 | May 29, 2025 | — | -$0.02 | — | — | — | — |
| — Q4 FY2024 | Dec 31, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 1, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2024 | Jun 30, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2024 | Mar 30, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2023 | Dec 31, 2023 | — | -$0.02 | — | $0.00B | — | — |
Q4 FY2025
Nov 28, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Jun 20, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 29, 2025
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 31, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 1, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Jun 30, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Mar 30, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Dec 31, 2023
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for BNXT.CN.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2025 | Nov 28, 2025 | — | $0.67 | $0.65 | -2.99% |
| — Q2 FY2025 | Jun 20, 2025 | — | $0.57 | $0.56 | -1.75% |
| — Q2 FY2025 | May 29, 2025 | — | $0.55 | $0.55 | +0.00% |
| — Q4 FY2024 | Dec 31, 2024 | — | $0.37 | $0.38 | +2.70% |
| — Q4 FY2024 | Nov 1, 2024 | — | $0.25 | $0.26 | +6.12% |
| — Q2 FY2024 | Jun 30, 2024 | — | $0.28 | $0.28 | +0.00% |
| — Q1 FY2024 | Mar 30, 2024 | — | $0.47 | $0.50 | +6.38% |
| — Q4 FY2023 | Dec 31, 2023 | — | $0.52 | $0.50 | -4.81% |
Q4 FY2025-2.99%
Report Date
Nov 28, 2025
EPS Beat/Miss
—
Price Before
$0.67
Price After
$0.65
Q2 FY2025-1.75%
Report Date
Jun 20, 2025
EPS Beat/Miss
—
Price Before
$0.57
Price After
$0.56
Q2 FY2025+0.00%
Report Date
May 29, 2025
EPS Beat/Miss
—
Price Before
$0.55
Price After
$0.55
Q4 FY2024+2.70%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$0.37
Price After
$0.38
Q4 FY2024+6.12%
Report Date
Nov 1, 2024
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.26
Q2 FY2024+0.00%
Report Date
Jun 30, 2024
EPS Beat/Miss
—
Price Before
$0.28
Price After
$0.28
Q1 FY2024+6.38%
Report Date
Mar 30, 2024
EPS Beat/Miss
—
Price Before
$0.47
Price After
$0.50
Q4 FY2023-4.81%
Report Date
Dec 31, 2023
EPS Beat/Miss
—
Price Before
$0.52
Price After
$0.50
Beat Rate0 / 8 quarters
Largest Move+6.38% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BNXT.CN ends December
BioNxt Solutions Inc. (BNXT.CN) most recently reported earnings on November 28, 2025 for Q4 FY2025, posting EPS of $-0.01 (in line with the analyst consensus of —). The next BNXT.CN earnings date is expected around September 1, 2026.
Each quarter, investors track BNXT.CN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BNXT.CN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BNXT.CN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BNXT.CN earnings · 4 questionsBioNxt Solutions Inc.'s next earnings report is expected around September 1, 2026. BNXT.CN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BNXT.CN historically reports after market close (AMC).
BNXT.CN earnings datewhen is BNXT.CN earningsBNXT.CN next earnings datewhen does BNXT.CN report earningsBNXT.CN earnings calendar
▸ Source: FMP · BioNxt Solutions Inc. SEC filings · US GAAP · BioNxt Solutions Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026